Today: 20 March 2026
Subscribe
Browse Category

NASDAQ:LLY 1 October 2025

Big Pharma’s Billion-Dollar Bet: Inside Eli Lilly’s $5B Virginia Factory and America’s New Drug Manufacturing Boom

Eli Lilly Stock Surges on Obesity-Drug Boom – Is $1,000 Next?

Eli Lilly shares surged nearly 9% to $832 intraday on Oct. 1 after closing at $763 on Sept. 30, driven by bullish options activity and optimism over its weight-loss and Alzheimer’s drugs. Q2 revenue jumped 38% to $15.56 billion, powered by GLP-1 treatments Mounjaro and ZepBound. The company raised full-year sales guidance to $60–$62 billion. Lilly faces a lawsuit from Texas over alleged incentives for prescriptions, which it denies.
1 October 2025
·

Stock Market Today

  • S&P 500 Shows Hidden Bear Market With 42% of Stocks Down 20% or More
    March 20, 2026, 8:44 AM EDT. A Morgan Stanley analysis reveals 42% of S&P 500 stocks, over 200 companies, are in a bear market-defined as a 20% or more drop from their 52-week highs-despite the index itself being down only 4%. The software sector leads losses with 97% of stocks down at least 20%, followed by automobiles at 75% and media & entertainment at 63%. Conversely, energy and utilities show resilience. The S&P 500 recently broke below its crucial 200-day moving average (DMA) after a 214-day stretch above it. Historical data since 2000 shows that such breaks often precede short-term market declines, with an average drop of 5.3% in the following month. Medium-term outlooks show mixed results, but caution is urged, especially amid adverse macro conditions.
Go toTop